Circulating endothelial cells as biomarkers for patients receiving bevacizumab
- PMID: 21376289
- DOI: 10.1016/S1470-2045(11)70051-1
Circulating endothelial cells as biomarkers for patients receiving bevacizumab
Comment on
-
Biomarkers to predict the clinical efficacy of bevacizumab in cancer.Lancet Oncol. 2010 Dec;11(12):1172-83. doi: 10.1016/S1470-2045(10)70232-1. Lancet Oncol. 2010. PMID: 21126687 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
